相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced OXPHOS, glutaminolysis and β-oxidation constitute the metastatic phenotype of melanoma cells
Mariana F. Rodrigues et al.
BIOCHEMICAL JOURNAL (2016)
Years of life lost due to metastatic melanoma in 12 countries
Aminata Thiam et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study
Hanna Eriksson et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses
Jamileh A. Nabizadeh et al.
JOURNAL OF IMMUNOLOGY (2016)
Conditional Melanoma Cancer Survival in the United States
Ray M. Merrill et al.
CANCERS (2016)
c-Myc modulation: a key role in melanoma drug response
Annalisa Fico et al.
CANCER BIOLOGY & THERAPY (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma
Jordan Wengrod et al.
SCIENCE SIGNALING (2015)
Pyruvate kinase: Function, regulation and role in cancer
William J. Israelsen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
Helena Cirenajwis et al.
ONCOTARGET (2015)
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma
Jordan Wengrod et al.
SCIENCE SIGNALING (2015)
A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
Charlotte Welinder et al.
PLOS ONE (2015)
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
Cristina Tringali et al.
BMC CANCER (2014)
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Helen Rizos et al.
CLINICAL CANCER RESEARCH (2014)
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma
Xuan Qu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Survival According to BRAF-V600 Tumor Mutations - An Analysis of 437 Patients with Primary Melanoma
Diana Meckbach et al.
PLOS ONE (2014)
A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging
Yutaka Sugihara et al.
PROTEOMICS (2014)
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients
M. Schlaak et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Clinical Characteristics and Outcomes With Specific BRAF and NRAS Mutations in Patients With Metastatic Melanoma
Amanda D. Bucheit et al.
CANCER (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
Donald L. Morton
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Katja Harbst et al.
CLINICAL CANCER RESEARCH (2012)
Cancer classification using the Immunoscore: a worldwide task force
Jerome Galon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
The role of BRAF V600 mutation in melanoma
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis
Matias E. Valsecchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ConsensusPathDB: toward a more complete picture of cell biology
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2011)
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
Matthew A. Price et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Tight Junction-Associated Signaling Pathways Modulate Cell Proliferation in Uveal Melanoma
Ashwath Jayagopal et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping
Sunghoon Kim et al.
NATURE REVIEWS CANCER (2011)
Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
Goran Jonsson et al.
CLINICAL CANCER RESEARCH (2010)
Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains
Yuki Ohkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
分享论文
